Skip to main content

Advertisement

SpringerLink
Log in

Management and Prevention of Venous Thromboembolism in Patients with COVID-19

  • Published:
Current Treatment Options in Cardiovascular Medicine Aims and scope Submit manuscript

Abstract

Purpose of review

Venous thromboembolism (VTE) is a common complication of COVID-19 infection. Throughout the COVID-19 pandemic, clinicians have faced the task of attempting to best prevent VTE while also balancing the associated risks of anticoagulation. Early in the pandemic, protocols differed by institution and clinician. This paper seeks to examine current available evidence and guidelines in order to clarify and provide recommendations on which prophylactic interventions should be used for patients, depending on the clinical scenario.

Recent findings

A randomized control trial (RCT) performed in 2021 revealed that critically ill patients who receive therapeutic anticoagulation do not have better outcomes than those who receive standard thromboprophylaxis. An RCT studying non-critically ill hospitalized patients revealed therapeutic anticoagulation increased organ-support free days. Study of COVID-19 outpatients reveals no clinical benefit of therapeutic or prophylactic anticoagulation.

Summary

Given these findings as well as recommendations from the American Society of Hematology, we conclude that patients who are critically ill should receive standard thromboprophylaxis, floor patients should receive therapeutic anticoagulation, and outpatients should receive neither. There is growing research in the field of treatment in VTE in COVID-19 patients. Based on the American College of Chest Physician guidelines, there are similar treatment recommendations for COVID-19 positive and negative patients diagnosed with a VTE. Due to caution regarding disease transmission and staff safety, there were not initial strong pushes toward invasive therapies and a focus was placed on medication management. With the availability of disease transmission and appropriate personal protective equipment (PPE) stocks, there is now consideration to pursue these catheter or surgical-based interventions. These recommendations may change in the future. Further research should be conducted, especially as new variants emerge and populations demonstrate increased immunity, both via vaccines and through natural infection.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

Papers of particular interest, published recently, have been highlighted as: •• Of major importance

  1. Ma L, Sahu SK, Cano M, Kuppuswamy V, Bajwa J, McPhatter J, Pine A, Meizlish M, Goshua G, Chang CH, Zhang H, Price C, Bahel P, Rinder H, Lei T, Day A, Reynolds D, Wu X, Schriefer R, Rauseo AM, Goss CW, O’Halloran JA, Presti RM, Kim AH, Gelman AE, Cruz CD, Lee AI, Mudd P, Chun HJ, Atkinson JP, Kulkarni HS. Increased complement activation is a distinctive feature of severe SARS-CoV-2 infection. bioRxiv [Preprint]. 2021 Feb 23:2021.02.22.432177. Update in: Sci Immunol. 2021;6(59). https://doi.org/10.1101/2021.02.22.432177. PMID: 33655244; PMCID: PMC7924264.

  2. Maier CL, Truong AD, Auld SC, Polly DM, Tanksley C-L, Duncan A. Covid-19-associated hyperviscosity: a link between inflammation and thrombophilia? The Lancet. 2020;395:1758–9.

    Article  CAS  Google Scholar 

  3. Poissy J, Goutay J, Caplan M, Parmentier E, Duburcq T, Lassalle F, Jeanpierre E, Rauch A, Labreuche J, Susen S. Lille ICU Haemostasis COVID-19 Group. Pulmonary embolism in patients with COVID-19: awareness of an increased prevalence. Circulation. 2020;142(2):184–186. https://doi.org/10.1161/CIRCULATIONAHA.120.047430. Epub 2020 Apr 24. PMID: 32330083.

  4. Middeldorp S, Coppens M, van Haaps TF, Foppen M, Vlaar AP, Müller MCA, Bouman CCS, Beenen LFM, Kootte RS, Heijmans J, Smits LP, Bonta PI, van Es N. Incidence of venous thromboembolism in hospitalized patients with COVID-19. J Thromb Haemost. 2020;18(8):1995–2002. https://doi.org/10.1111/jth.14888. Epub 2020 Jul 27. PMID: 32369666; PMCID: PMC7497052.

  5. Bilaloglu S, Aphinyanaphongs Y, Jones S, Iturrate E, Hochman J, Berger JS. Thrombosis in hospitalized patients with COVID-19 in a New York City Health System. JAMA. 2020;324(8):799–801. https://doi.org/10.1001/jama.2020.13372.PMID:32702090;PMCID:PMC7372509.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Hill JB, Garcia D, Crowther M, Savage B, Peress S, Chang K, Deitelzweig S. Frequency of venous thromboembolism in 6513 patients with COVID-19: a retrospective study. Blood Adv. 2020;4(21):5373–7. https://doi.org/10.1182/bloodadvances.2020003083.PMID:33137202;PMCID:PMC7656921.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Ssentongo P, Ssentongo AE, Voleti N, Groff D, Sun A, Ba DM, Nunez J, Parent LJ, Chinchilli VM, Paules CI. SARS-COV-2 vaccine effectiveness against infection, symptomatic and severe COVID-19: A systematic review and meta-analysis. BMC Infect Dis. 2022. https://doi.org/10.1186/s12879-022-07418-y.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Wichmann D, Sperhake J-P, Lütgehetmann M, et al. Autopsy findings and venous thromboembolism in patients with covid-19. Ann Intern Med. 2020;173:1030.

    Article  PubMed  Google Scholar 

  9. •• REMAP-CAP Investigators, ACTIV-4a Investigators, ATTACC Investigators, et al. Therapeutic anticoagulation with heparin in critically ill patients with covid-19. N Engl J Med. 2021;385:777–789. Critically ill COVID-19 patients should receive standard thromboprophylaxis for best clinical outcomes. 

  10. •• ATTACC Investigators, ACTIV-4a Investigators, REMAP-CAP Investigators, et al. Therapeutic anticoagulation with heparin in noncritically ill patients with covid-19. N Engl J Med 2021;385:790–802. Non-critically ill COVID-19 patients should receive therapeutic levels of anticoagulation for best clinical outcomes.

  11. Stone GW, Farkouh ME, Lala A, et al. Anticoagulation strategies in non-critically ill patients hospitalized with covid-19: a randomized clinical trial. J Am Coll Cardiol. 2023. https://doi.org/10.1016/j.jacc.2023.02.041.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Connors JM, Brooks MM, Sciurba FC, et al. Effect of antithrombotic therapy on clinical outcomes in outpatients with clinically stable symptomatic COVID-19. JAMA. 2021;326:1703.

    Article  CAS  PubMed  Google Scholar 

  13. Jara-Palomares L, Bikdeli B, Jiménez D, Muriel A, Martin Del Pozo M, Demelo-Rodríguez P, Monreal M. Rate of recurrence after discontinuing anticoagulation therapy in patients with COVID-19-associated venous thromboembolism. JAMA Intern Med. 2022;182(12):1326–8. https://doi.org/10.1001/jamainternmed.2022.4954.PMID:36342711;PMCID:PMC9641587.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. •• Moores LK, Tritschler T, Brosnahan S, et al. Prevention, diagnosis, and treatment of VTE in patients with coronavirus disease 2019. Chest. 2020;158:1143–63. Patients with acute pulmonary embolism associated with hypotension or signs of obstructive shock, who do not have a high bleeding risk, should recieve systemic thrombolytics.

    Article  CAS  PubMed  Google Scholar 

  15. Roncon L, Zuin M, Zonzin P. Fibrinolysis in COVID-19 patients with hemodynamic unstable acute pulmonary embolism: yes or no? J Thromb Thrombolysis. 2020;50:221–2.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Marginean A, Masic D, Brailovsky Y, Fareed J, Darki A. Difficulties of managing submassive and massive pulmonary embolism in the era of COVID-19. JACC: Case Rep 2020;2:1383–1387.

  17. Li Y, Deng J, Liao J, Li H, Wang W, Zhang D, Wang J, Zhang L, Xie M. Feasibility of bedside ultrasound-guided inferior vena cava filter implantation in COVID-19 patients with deep venous thrombosis. QJM: Int J Med 2020;113:817–819.

  18. Georgiadis GS, Argyriou C, Tottas S, Foutzitzi S, Drosos G. Extensive inferior vena cava thrombosis related to COVID-19 infection in a patient with retrievable filter due to multiple pelvic bone fractures. Vasc Specialist Int. 2022. https://doi.org/10.5758/vsi.210070.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Ismayl M, Machanahalli Balakrishna A, Aboeata A, Gupta T, Young MN, Altin SE, Aronow HD, Goldsweig AM. Meta-analysis comparing catheter-directed thrombolysis versus systemic anticoagulation alone for submassive pulmonary embolism. Am J Cardiol. 2022;178:154–62.

    Article  PubMed  Google Scholar 

  20. Voci D, Zbinden S, Micieli E, Kucher N, Barco S. Fixed-dose ultrasound-assisted catheter-directed thrombolysis for acute pulmonary embolism associated with covid-19. Viruses. 2022;14:1606.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Raval M, Rajendran S, Stephen E. The outcome of catheter-directed thrombolysis in covid-19-associated deep vein thrombosis. Vasc Endovascular Surg. 2022;56:258–62.

    Article  PubMed  Google Scholar 

  22. Petrov I, Stankov Z, Dobrev G, Polomski P. Covid-19 infection complicated with acute pulmonary embolism treated with percutaneous pulmonary artery thrombectomy: a case report. Eur Heart J Case Rep. 2022. https://doi.org/10.1093/ehjcr/ytac227.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Carlsson TL, Walton B, Collin G. Pulmonary artery thrombectomy – a life-saving treatment in a patient with presumed covid-19 complicated by a massive pulmonary embolus. Br J Haematol. 2020. https://doi.org/10.1111/bjh.16920.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Yu A, Ding W, Lin W, Cai J, Huang W. Application of pulmonary rehabilitation in patients with pulmonary embolism (review). Exp Ther Med. 2021. https://doi.org/10.3892/etm.2021.11019.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Sachdeva A, Dalton M, Lees T. Graduated compression stockings for prevention of deep vein thrombosis. Cochrane Database Syst Rev. 2018. https://doi.org/10.1002/14651858.cd001484.pub4.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Vanek VW. Meta-analysis of effectiveness of intermittent pneumatic compression devices with a comparison of thigh-high to knee-high sleeves. Am J Surg. 1998;64:1050–8.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Emory University School of Medicine, 100 Woodruff Circle, Atlanta, GA, 30322, USA

    Olivia Cote BS, Shaunak Varma MD, MPH, Alexander Vakili MD & Bryan Wells MD

Authors
  1. Olivia Cote BS
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shaunak Varma MD, MPH
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Alexander Vakili MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Bryan Wells MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Bryan Wells MD.

Ethics declarations

Conflict of Interest

Olivia Cote declares that she has no conflict of interest. Shaunak Varma declares that he has no conflict of interest. Alexander Vakili declares that he has no conflict of interest. Bryan Wells declares that he has no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cote, O., Varma, S., Vakili, A. et al. Management and Prevention of Venous Thromboembolism in Patients with COVID-19. Curr Treat Options Cardio Med 25, 515–524 (2023). https://doi.org/10.1007/s11936-023-01008-0

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11936-023-01008-0

Keywords

Search

Navigation